What is CG Oncology's stock issuance proceeds?

CG Oncology (CGON) reported stock issuance proceeds of $391.55M in Q1 2026.

How has CG Oncology's stock issuance proceeds changed year-over-year?

CG Oncology's stock issuance proceeds increased by 57312.0% year-over-year, from $682K to $391.55M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

CG Oncology CGON Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Gilead SciencesGILD

$166M-34.1%

ImmunityBio, Inc.IBRX

$971K+341%

Cogent Biosciences, Inc.COGT

$5.76M+4,132%

Tango TherapeuticsTNGX

$17.61M+880,150%

Immunovant, Inc.IMVT

$0-100%

Summit TherapeuticsSMMT

$3.8M+88.1%

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's stock issuance proceeds?: CG Oncology (CGON) reported stock issuance proceeds of $391.55M in Q1 2026.
How has CG Oncology's stock issuance proceeds changed year-over-year?: CG Oncology's stock issuance proceeds increased by 57312.0% year-over-year, from $682K to $391.55M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.